| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:1145-1153.)
© 2005 American Heart Association, Inc.
Hypertension |
From the Department of Surgery, Duke University Medical Center, Durham, NC (J.R.K.), and the Eugene Feiner Laboratory for Vascular Biology and Thrombosis, Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pa (R.-H.Z., D.M.H., C.A.D., A.D.E.). Dr Keys is now at the Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia.
Correspondence to Andrea D. Eckhart, Room 309 College, 1025 Walnut St, Thomas Jefferson University, Philadelphia, PA 19107. E-mail andrea.eckhart{at}jefferson.edu
Received December 22, 2004; revision received April 6, 2005; accepted May 10, 2005.
Background— Essential hypertension involves an increase in sympathetic nervous system activity and an associated decrease in β-adrenergic receptor (AR)–mediated dilation. In addition, increased levels of G protein–coupled receptor (GPCR) kinases (GRKs), which regulate GPCR signaling, are associated with increased blood pressure (BP).
Methods and Results— We generated transgenic mice with
2-fold vascular smooth muscle (VSM)–specific overexpression of GRK5 to recapitulate a selective aspect of hypertension and understand the impact on GPCR regulation of BP. VSM-GRK5 mice were hypertensive, with a 25% to 35% increase in BP, whereas there was no concomitant cardiac or VSM hypertrophy. BP elevations were segregated with sex, with male mice having higher levels than female mice, and ovariectomy did not alter this phenotype. BP was restored to control values with pertussis toxin Gi-signaling inhibition or chronic β1AR inhibition after 7 days of CGP20712A, whereas the β2AR antagonist ICI 118,551 was ineffective.
1AR response was not altered, nor was βAR-mediated dilation in male blood vessels, whereas norepinephrine sensitivity was increased. In contrast, female VSM-GRK5 blood vessels have diminished βAR-mediated dilation and enhanced sensitivity to angiotensin II (Ang II).
Conclusions— Our data suggest that in both male and female mice, VSM-specific overexpression of GRK5 elevates BP mediated by Gi and, at least in part, by β1AR in males and Ang II receptors in females. Understanding mechanisms underlying an increase in VSM-GRK5 may have a profound influence on the use and development of antihypertensive therapeutics.
This article has been cited by other articles:
![]() |
H. I. Cohn, Y. Xi, S. Pesant, D. M. Harris, T. Hyslop, B. Falkner, and A. D. Eckhart G Protein-Coupled Receptor Kinase 2 Expression and Activity Are Associated With Blood Pressure in Black Americans Hypertension, July 1, 2009; 54(1): 71 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Cohn, D. M. Harris, S. Pesant, M. Pfeiffer, R.-H. Zhou, W. J. Koch, G. W. Dorn 2nd, and A. D. Eckhart Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances {alpha}1D-adrenergic receptor constriction Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1695 - H1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, V. A. M. Villar, G. M. Eisner, S. M. Williams, R. A. Felder, and P. A. Jose G Protein-Coupled Receptor Kinase 4: Role in Blood Pressure Regulation Hypertension, June 1, 2008; 51(6): 1449 - 1455. [Full Text] [PDF] |
||||
![]() |
H. Cho, C. Park, I.-Y. Hwang, S.-B. Han, D. Schimel, D. Despres, and J. H. Kehrl Rgs5 Targeting Leads to Chronic Low Blood Pressure and a Lean Body Habitus Mol. Cell. Biol., April 15, 2008; 28(8): 2590 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou, and A. D. Eckhart Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3072 - H3079. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |